Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug ...

Ozempic: Approved for managing type 2 diabetes and reducing the risk of major cardiovascular events in adults with type 2 ...

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Thomas Kraut, 59, was diagnosed as obese. After 12 years, a doctor finally realized that his rapidly growing belly actually ...

Karan Johar’s recent weight loss has sparked rumors linking him to Ozempic, a diabetes drug now popular for its weight-loss ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Semaglutide, the main ingredient in Ozempic and Wegovy, improves type 2 diabetes, heart disease, smoking, and alcohol consumption, which all raise the risk of Alzheimer’s.